Ask your doctor about TECENTRIQ, given once every 3 weeks* as an intravenous infusion†.
urination, flu-like symptoms, and pain
• Severe infusion reactions—signs and
symptoms of infusion reactions may
include chills or shaking, itching or rash,
flushing, shortness of breath or wheezing,
dizziness, fever, feeling like passing out,
back or neck pain, and swelling of your
face or lips
Before you receive TECENTRIQ, tell your
healthcare provider about all your medical
conditions, including if you:
• Have immune system problems (such as
Crohn’s disease, ulcerative colitis, or lupus);
have had an organ transplant; have lung or
breathing problems; have liver problems;
have a condition that affects your nervous
system (such as myasthenia gravis or
Guillain-Barré syndrome); or are being
• Are pregnant or plan to become pregnant
– TECENTRIQ can harm your unborn baby
– If you are able to become pregnant, you
should use an effective method of birth
control during your treatment and for
at least 5 months after the last dose of
• Are breastfeeding or plan to breastfeed
– It is not known if TECENTRIQ passes into
your breast milk
– Do not breastfeed during treatment and
for at least 5 months after the last dose
Tell your healthcare provider about all the
medicines you take, including prescription
and over-the-counter medicines, vitamins,
and herbal supplements.
The most common side effects of
TECENTRIQ in urothelial carcinoma include:
• Feeling tired
• Decreased appetite
• Urinary tract infection
TECENTRIQ may cause fertility problems in
females, which may affect the ability to have
children. Talk to your healthcare provider if
you have concerns about fertility.
These are not all the possible side effects of
TECENTRIQ. Ask your healthcare provider or
pharmacist for more information.
You may report side effects to the FDA at
1-800-FDA-1088 or www.fda.gov/medwatch.
You may also report side effects to Genentech
Please see Summary of Medication Guide
on the following page.
© 2016 Genentech USA, Inc. All rights reserved.
PDL/062416/0164 Printed in USA.
* A 60-minute initial infusion and, if tolerated, a 30-minute treatment every 3 weeks.
† Your healthcare provider will give you TECENTRIQ into your vein through an intravenous (IV) line over 30-60 minutes.
A path forward